Story

Henry Schein Shares Fall After Announcing Departure of Three Top Executives

ENTHMSVIIDZHZH-TWJAKOHI
Jul 30, 20262 min read
Henry Schein Shares Fall After Announcing Departure of Three Top Executives
Text size
Background

Henry Schein Inc. (NASDAQ:HSIC) shares fell on Thursday after the company announced a major leadership restructuring that includes the departure of three senior executives from their current positions. The stock traded down 1.9% following the news from the Melville, New York-based healthcare products distributor.

Executive Departures and Restructuring

Henry Schein announced it is creating a new Henry Schein Leadership Team to replace its Executive Management Committee. As part of this overhaul, three long-tenured executives will transition out of their roles effective October 30, 2026, though they will remain with the company as Senior Advisors.

The departing executives are:

  • Michael S. Ettinger, Executive Vice President and Chief Operating Officer
  • Mark E. Mlotek, Executive Vice President and Chief Strategy Officer
  • James Mullins, Senior Vice President of Global Supply Chain

The company also stated it will integrate its global supply chain organization with its global distribution group to bring supply chain management closer to the customers served by its distribution businesses.

Sample IUX Markets – In-articleAd

Strategic Rationale

According to Chief Executive Officer Fred Lowery, the new leadership structure is intended to help Henry Schein "become simpler, prioritize and make decisions faster, better execute on our priorities, and become an even more customer-centric organization." The changes are designed to streamline corporate functions and improve customer focus.

Investors reacted to the significant management shake-up, which involves executives with what the company described as over 100 years of combined experience. Chairman William K. Daniel said in a statement that the company "owes a debt of gratitude" to the three executives for their contributions.

Company Background

Henry Schein is a major global provider of healthcare products, services, and technology, serving more than one million customers. The company reported annual sales of $13.2 billion in 2025. The departing executives have played key roles in building the company's infrastructure, with Mlotek having served on the Board of Directors for 30 years.

Read next

More on Stocks
Back to latest news

LATEST